Swiss National Bank decreased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 4.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 202,900 shares of the biotechnology company's stock after selling 9,900 shares during the quarter. Swiss National Bank owned 0.27% of Axon Enterprise worth $120,588,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Groupama Asset Managment purchased a new position in Axon Enterprise in the third quarter valued at $200,000. Massachusetts Financial Services Co. MA purchased a new stake in shares of Axon Enterprise during the third quarter worth approximately $120,553,000. Proficio Capital Partners LLC acquired a new stake in Axon Enterprise in the fourth quarter valued at approximately $78,414,000. Westfield Capital Management Co. LP lifted its stake in Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company's stock worth $469,661,000 after acquiring an additional 127,769 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its holdings in Axon Enterprise by 328.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company's stock worth $86,354,000 after acquiring an additional 111,405 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company's stock.
Insider Buying and Selling
In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares of the company's stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeri Williams sold 307 shares of the company's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,792 shares of company stock valued at $1,087,843 over the last three months. 5.70% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
AXON has been the topic of a number of analyst reports. Needham & Company LLC restated a "buy" rating and issued a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. Northcoast Research downgraded Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. TD Cowen started coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a "buy" rating and a $700.00 price objective for the company. The Goldman Sachs Group raised their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. Finally, Morgan Stanley raised Axon Enterprise from an "equal weight" rating to an "overweight" rating and upped their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $604.67.
View Our Latest Report on AXON
Axon Enterprise Stock Performance
Shares of NASDAQ:AXON traded up $28.12 on Wednesday, reaching $568.11. The company's stock had a trading volume of 575,893 shares, compared to its average volume of 852,229. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The stock has a market capitalization of $43.53 billion, a P/E ratio of 146.80, a PEG ratio of 5.17 and a beta of 1.12. The stock's 50-day moving average is $592.66 and its two-hundred day moving average is $539.27. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.
Axon Enterprise Company Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.